gadolinium dtpa has been researched along with Fisher Syndrome in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dörfler, A; Kiphuth, IC; Kollmar, R; Lunkenheimer, J; Saake, M; Schwab, S | 1 |
| Hirata, K; Tanaka, H; Yuki, N | 1 |
| Hattori, M; Kamimoto, K; Mitake, S; Takada, K; Yamada, K | 1 |
3 other study(ies) available for gadolinium dtpa and Fisher Syndrome
| Article | Year |
|---|---|
Bilateral enhancement of the cranial nerves III-XII in severe Miller-Fisher syndrome.
Topics: Cranial Nerves; Female; Gadolinium DTPA; Humans; Immunosuppression Therapy; Miller Fisher Syndrome; Treatment Outcome; Young Adult | 2009 |
Trochlear nerve enhancement on three-dimensional magnetic resonance imaging in Fisher syndrome.
Topics: Aged; Contrast Media; Cranial Nerve Diseases; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Miller Fisher Syndrome; Trochlear Nerve | 1998 |
[A case of Miller Fisher syndrome with gadolinium-enhancing lesions in the cranial nerves and the cauda equina on magnetic resonance imaging].
Topics: Adult; Autoantibodies; Cauda Equina; Cranial Nerves; Female; Gadolinium DTPA; Gangliosides; Humans; Immunoglobulin G; Immunoglobulins, Intravenous; Magnetic Resonance Imaging; Miller Fisher Syndrome; Treatment Outcome | 1999 |